Related Experiment Video
Updated: May 31, 2026

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
Published on: August 11, 2018
Characteristics of children with positive tuberculin skin test
Arzu Babayiğit Hocaoğlu1, Duygu Olmez Erge, Ozden Anal
1Department of Children Health and Diseases, Division of Children Allergy, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey. arbabayigit@yahoo.com
Insights
Childhood latent tuberculosis diagnosis is complicated by factors like age and BCG vaccination history affecting tuberculin skin test (TST) results. Newer in vitro tests may offer improved accuracy despite higher costs.
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- Latent tuberculosis infection (LTBI) diagnosis in children presents challenges.
- The tuberculin skin test (TST) is a common diagnostic tool, but its interpretation can be affected by various factors.
- Identifying risk factors for positive TST in pediatric populations is crucial for accurate diagnosis and treatment.
Purpose of the Study:
- To characterize children diagnosed with latent tuberculosis infection using a positive TST.
- To evaluate potential risk factors influencing TST results in children.
- To assess the impact of demographic and clinical factors on TST reactivity in pediatric LTBI.
Main Methods:
- Retrospective study evaluating 81 children with positive TST.
- Data collection included patient demographics, medical history (atopy, respiratory infections, family history of TB/atopy), BCG vaccination status, and physical examination findings.
- Statistical analysis focused on factors affecting TST reaction size.
Main Results:
- Patient age, number of BCG vaccination scars, and BCG vaccination status significantly influenced TST reaction size.
- Factors such as time since last BCG, family history of TB, household contact with TB cases, smoking exposure, household size, and allergic respiratory disease did not significantly affect TST size.
- Only 16% of children with positive TST had known contact with an active TB case.
Conclusions:
- Pediatric TST results are significantly affected by patient age and BCG vaccination history (scars and vaccination status).
- These factors can complicate the diagnosis of LTBI and the decision to initiate prophylactic treatment in children.
- The study suggests that newer, more accurate in vitro tests, despite higher costs and laboratory requirements, may be valuable for diagnosing pediatric LTBI.
Abstract:
The aim of the study was to define the characteristics of children with latent tuberculosis diagnosed with positive tuberculin skin test (TST) and evaluate potential risk factors in children with positive TST. Children followed with the diagnosis of latent tuberculosis infection were included in the study retrospectively. Demographic characteristics of patients including history of atopy, respiratory infections, family history of tuberculosis and atopy, number of BCG vaccinations, findings of physical examination and laboratory data were extracted from patient's file. Eighty-one children (51 male, 30 female) who had positive TST were retrospectively evaluated in the study. Mean age of the patients was 8.00 ± 4.00 years. Only 13 (16%) of the children had contact with a case who had active tuberculosis. It was shown that the age of the patients, number of BCG scars and BCG vaccination significantly affected TST reaction size. TST size was not affected with time passed after last dose of BCG vaccination, family history of tuberculosis, presence of TST positive case in the family, exposure to cigarette smoke, number of household family members and presence of respiratory allergic disease. The patient's age, numbers of BCG vaccination and BCG scars significantly affect TST results in childhood. This may cause difficulty in diagnosing latent tuberculosis infection and in decision of initiating prophylactic treatment. The results of this study may show that recently developed, more accurate and convenient in vitro tests that they have higher costs and require sophisticated laboratory, can be used to diagnose latent tuberculosis.
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions